Advertisement

Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review

      Abstract

      Background

      Women with depressive or bipolar disorders are at an increased risk for unintended pregnancy.

      Objective

      To examine the safety of hormonal contraception among women with depressive and bipolar disorders.

      Methods

      We searched for articles published through January 2016 on the safety of using any hormonal contraceptive method among women with depressive or bipolar disorders, including those who had been diagnosed clinically or scored above threshold levels on a validated screening instrument. Outcomes included changes in symptoms, hospitalization, suicide and modifications in medication regimens such as increase or decrease in dosage or changes in type of drug.

      Results

      Of 2376 articles, 6 met the inclusion criteria. Of three studies that examined women clinically diagnosed with depressive or bipolar disorder, one found that oral contraceptives (OCs) did not significantly change mood across the menstrual cycle among women with bipolar disorder, whereas mood did significantly change across the menstrual cycle among women not using OCs; one found no significant differences in the frequency of psychiatric hospitalizations among women with bipolar disorder who used depot medroxyprogesterone acetate (DMPA), intrauterine devices (IUDs) or sterilization; and one found no increase in depression scale scores among women with depression using and not using OCs, for both those treated with fluoxetine and those receiving placebo. Of three studies that examined women who met a threshold for depression on a screening instrument, one found that adolescent girls using combined OCs (COCs) had significantly improved depression scores after 3 months compared with placebo, one found that OC users had similar odds of no longer being depressed at follow-up compared with nonusers, and one found that COC users were less frequently classified as depressed over 11 months than IUD users.

      Conclusions

      Limited evidence from six studies found that OC, levonorgestrel-releasing IUD and DMPA use among women with depressive or bipolar disorders was not associated with worse clinical course of disease compared with no hormonal method use.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kessler RC
        • Berglund P
        • Demler O
        • Jin R
        • Merikangas KR
        • Walters EE
        Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.
        Arch Gen Psychiatry. 2005; 62: 593-602
        • Association AP
        Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.
        American Psychiatric Association, Arlington, VA2013
        • Farr SL
        • Bitsko RH
        • Hayes DK
        • Dietz PM
        Mental health and access to services among US women of reproductive age.
        Am J Obstet Gynecol. 2010; 203: 542.e1-542.e9https://doi.org/10.1016/j.ajog.2010.07.007
        • Hasin DS
        • Goodwin RD
        • Stinson FS
        • Grant BF
        Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions.
        Arch Gen Psychiatry. 2005; 62: 1097-1106
        • Phillips ML
        • Kupfer DJ
        Bipolar disorder diagnosis: challenges and future directions.
        Lancet. 2013; 381: 1663-1671
        • Tondo L
        • Lepri B
        • Cruz N
        • Baldessarini RJ
        Age at onset in 3014 Sardinian bipolar and major depressive disorder patients.
        Acta Psychiatr Scand. 2010; 121 ([Epub 2009 Dec 23]): 446-452https://doi.org/10.1111/j.600-0447.2009.01523.x
        • Merikangas KR
        • Akiskal HS
        • Angst J
        • et al.
        Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.
        Arch Gen Psychiatry. 2007; 64: 543-552
        • Magalhaes PV
        • Kapczinski F
        • Kauer-Sant'Anna M
        Use of contraceptive methods among women treated for bipolar disorder.
        Arch Womens Ment Health. 2009; 12 ([Epub 2009 Mar 10]): 183-185https://doi.org/10.1007/s00737-009-0060-y
        • Curtis V
        Women are not the same as men: specific clinical issues for female patients with bipolar disorder.
        Bipolar Disord. 2005; 7: 16-24
        • Berenson AB
        • Asem H
        • Tan A
        • Wilkinson GS
        Continuation rates and complications of intrauterine contraception in women diagnosed with bipolar disorder.
        Obstet Gynecol. 2011; 118: 1331-1336
        • Meade CS
        • Sikkema KJ
        Voluntary HIV testing among adults with severe mental illness: frequency and associated factors.
        AIDS Behav. 2005; 9: 465-473
        • Alder J
        • Fink N
        • Bitzer J
        • Hosli I
        • Holzgreve W
        Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature.
        J Matern Fetal Neonatal Med. 2007; 20: 189-209
        • Stein A
        • Pearson RM
        • Goodman SH
        • et al.
        Effects of perinatal mental disorders on the fetus and child.
        Lancet. 2014; 384 ([Epub 2014 Nov 14]): 1800-1819https://doi.org/10.016/S0140–6736(14)61277–0
        • Yatham LN
        • Kennedy SH
        • Parikh SV
        • et al.
        Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
        Bipolar Disord. 2013; 15 ([Epub 2012 Dec 12]): 1-44https://doi.org/10.1111/bdi.12025
        • Abajobir AA
        • Maravilla JC
        • Alati R
        • Najman JM
        A systematic review and meta-analysis of the association between unintended pregnancy and perinatal depression.
        J Affect Disord. 2016; 192 ([Epub Dec 17]): 56-63https://doi.org/10.1016/j.jad.2015.12.008
        • Hall KS
        • White KO
        • Rickert VI
        • Reame N
        • Westhoff C
        Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women.
        Contraception. 2012; 86 ([Epub Jun 4]): 518-525https://doi.org/10.1016/j.contraception.2012.04.010
        • Goldzieher JW
        • Zamah NM
        Oral contraceptive side effects: where's the beef?.
        Contraception. 1995; 52: 327-335
        • Westhoff CL
        • Heartwell S
        • Edwards S
        • et al.
        Oral contraceptive discontinuation: do side effects matter?.
        Am J Obstet Gynecol. 2007; 196 ([discussion .e6–7]): 412.e1-412.e6
        • Oinonen KA
        • Mazmanian D
        To what extent do oral contraceptives influence mood and affect?.
        J Affect Disord. 2002; 70: 229-240
        • Shamseer L
        • Moher D
        • Clarke M
        • et al.
        Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
        BMJ. 2015; 349: g7647https://doi.org/10.1136/bmj.g7647
        • Harris RP
        • Helfand M
        • Woolf SH
        • Lohr KN
        • Mulrow CD
        • Teutsch SM
        • et al.
        Current methods of the U.S. Preventive Services Task Force: a review of the process.
        Am J Prev Med. 2001; 20: 21-35
        • O'Connell K
        • Davis AR
        • Kerns J
        Oral contraceptives: side effects and depression in adolescent girls.
        Contraception. 2007; 75: 299-304
        • Duke JM
        • Sibbritt DW
        • Young AF
        Is there an association between the use of oral contraception and depressive symptoms in young Australian women?.
        Contraception. 2007; 75: 27-31
        • Rasgon N
        • Bauer M
        • Glenn T
        • Elman S
        • Whybrow PC
        Menstrual cycle related mood changes in women with bipolar disorder.
        Bipolar Disord. 2003; 5: 48-52
        • Koke SC
        • Brown EB
        • Miner CM
        Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy.
        Am J Obstet Gynecol. 2002; 187: 551-555
        • Herzberg BN
        • Draper KC
        • Johnson AL
        • Nicol GC
        Oral contraceptives, depression, and libido.
        Br Med J. 1971; 3: 495-500
        • Berry-Bibee EN
        • Kim MJ
        • Simmons KB
        • Tepper NK
        • Riley HEM
        • Pagano HP
        • et al.
        Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review.
        Contraception. 2016; 94: 650-667
        • Gavin NI
        • Gaynes BN
        • Lohr KN
        • Meltzer-Brody S
        • Gartlehner G
        • Swinson T
        Perinatal depression: a systematic review of prevalence and incidence.
        Obstet Gynecol. 2005; 106: 1071-1083